Australia’s life sciences ecosystem is experiencing sustained growth, driven by advances in biotechnology, digital health, precision medicine, agricultural innovation and materials science. While pharmaceuticals continue to dominate in terms of patent filings and regulatory complexity, the broader life sciences sector – encompassing agtech, medtech and next-generation materials such as semiconductors and battery technologies – is rapidly expanding.
Against this backdrop, intellectual property (IP) rights, particularly patents, play a central role in enabling innovation, attracting investment and guiding commercialisation strategies. Our Chemistry Life Sciences team have recently authored a chapter for IAM detailing how sector-specific trends and legal challenges highlight the importance of forward-looking IP strategy in Australia.
The chapter offers a strategic overview of the Australian life sciences IP environment, exploring sector-specific trends, legal challenges and opportunities to protect and leverage IP assets across the innovation life cycle.
Read the chapter here.
